Europe Narcolepsy Market to 2027 - Regional Analysis and Forecasts By Type (Narcolepsy with Cataplexy, Narcolepsy without Cataplexy, and Secondary Narcolepsy); Product (Central Nervous System (CNS) Stimulants, Sodium Oxybate, and Antidepressants); Distribution Channel (Hospital Pharmacies and Retail Pharmacies) and Country

1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

2.           Europe Narcolepsy Market – Key Takeaways

3.           Europe Narcolepsy Market – Market Landscape

3.1         Overview

3.2         Market Segmentation

3.2.1        Europe Narcolepsy Market – By Type

3.2.2        Europe Narcolepsy Market – By Product

3.2.3        Europe Narcolepsy Market – By Distribution Channel

3.2.4        Europe Narcolepsy Market – By Country

3.3         PEST Analysis

4.           Europe Narcolepsy Market-Key Dynamics

4.1         Key Market Drivers

4.1.1        Growing Research and Developments

4.1.2        Increasing Awareness Across the Region

4.2         Key Market Restraints

4.2.1        Challenge Related to Narcolepsy

4.3         Key Market Opportunity

4.3.1        Reimbursement For Drugs

4.4         Future Trend

4.4.1        Developments in Pharmaceutical Sector to Treat Narcolepsy

4.5         Impact Analysis Of Drivers and Restraints

5.           Narcolepsy Market – Regional Analysis

5.1         Europe Narcolepsy Market Revenue Forecasts and Analysis

5.2         Performance Of Key Players

5.2.1        Jazz Pharmaceuticals plc

5.2.2        Teva Pharmaceutical Industries Ltd.

6.           Narcolepsy Market Analysis and Forecasts to 2027 – Type

6.1         Overview

6.2         Type Market Revenue and Forecasts Analysis (US$ Mn)

6.3         Europe Narcolepsy With Cataplexy Market Revenue and Forecasts To 2027, By Type (Us$ Mn)

6.4         Narcolepsy With Cataplexy Market

6.4.1        Overview

6.4.2        Narcolepsy With Cataplexy Market Revenue and Forecast to 2027 (US$ Mn)

6.5         Narcolepsy Without Cataplexy Market

6.5.1        Overview

6.5.2        Narcolepsy Without Cataplexy Market Revenue and Forecast to 2027 (US$ Mn)

6.6         Secondary Narcolepsy Market

6.6.1        Overview

6.6.2        Secondary Narcolepsy Market Revenue and Forecast to 2027 (US$ Mn)

7.           Narcolepsy Market Analysis and Forecasts to 2027 – Product

7.1         Overview

7.2         Product Market Revenue and Forecasts Analysis (US$ Mn)

7.3         Europe Narcolespy Market Revenue and Forecasts To 2027, By Product (US$ Mn)

7.4         Central Nervous System Stimulants Market

7.4.1        Overview

7.4.2        Central Nervous System Stimulants Market Revenue and Forecast to 2027 (US$ Mn)

7.5         Sodium Oxybate Market

7.5.1        Overview

7.5.2        Sodium Oxybate Market Revenue and Forecast to 2027 (US$ Mn)

7.6         Antidepressants Market

7.6.1        Overview

7.6.2        Antidepressants Market Revenue and Forecast to 2027 (US$ Mn)

8.           Narcolepsy Market Analysis and Forecasts to 2027 – Distribution Channel

8.1         Overview

8.2         Distribution Channel Market Revenue and Forecasts Analysis (US$ Mn)

8.3         Europe Narcolespy Market Revenue and Forecasts To 2027, By End User (US$ Mn)

8.4         Hospital Pharmacies Market

8.4.1        Overview

8.4.2        Hospital Pharmacies Market Revenue and Forecast to 2027 (US$ Mn)

8.5         Retail Pharmacies Market

8.5.1        Overview

8.5.2        Retail Pharmacies Market Revenue and Forecast to 2027 (US$ Mn)

9.           Narcolepsy Market Revenue And Forecasts To 2027 – Geographical Analysis

9.1         Europe Narcolepsy Market

9.1.1        Overview

9.1.2        Europe Narcolepsy Market Revenue Overview, by Country (2017) (US$ Mn)

9.1.3        Europe Narcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)

9.1.4        Europe Narcolepsy Market Revenue And Forecasts to 2027, By Type (US$ Mn)

9.1.5        Europe Narcolepsy Market Revenue And Forecasts to 2027, By Product (US$ Mn)

9.1.6        Europe Narcolepsy Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)

9.1.7        Europe Narcolepsy Market Revenue and Forecasts to 2027, By Country (%)

9.1.8        Germany Narcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)

9.1.9        Germany Narcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)

9.1.9.1          Germany Narcolepsy Market Revenue And Forecasts to 2027, By Type (US$ Mn)

9.1.9.2          Germany Narcolepsy Market Revenue And Forecasts to 2027, By Product (US$ Mn)

9.1.9.3          Germany Narcolepsy Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)

9.1.10     UK Narcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)

9.1.11     UK Narcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)

9.1.11.1       UK Narcolepsy Market Revenue And Forecasts to 2027, By Type (US$ Mn)

9.1.11.2       UK Narcolepsy Market Revenue And Forecasts to 2027, By Product (US$ Mn)

9.1.11.3       UK Narcolepsy Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)

9.1.12     France Narcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)

9.1.13     France Narcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)

9.1.13.1       France Narcolepsy Market Revenue And Forecasts to 2027, By Type (US$ Mn)

9.1.13.2       France Narcolepsy Market Revenue And Forecasts to 2027, By Product (US$ Mn)

9.1.13.3       France Narcolepsy Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)

9.1.14     Italy Narcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)

9.1.15     Italy Narcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)

9.1.15.1       Italy Narcolepsy Market Revenue And Forecasts to 2027, By Type (US$ Mn)

9.1.15.2       Italy Narcolepsy Market Revenue And Forecasts to 2027, By Product (US$ Mn)

9.1.15.3       Italy Narcolepsy Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)

9.1.16     Spain Narcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)

9.1.17     Spain Narcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)

9.1.17.1       Spain Narcolepsy Market Revenue And Forecasts to 2027, By Type (US$ Mn)

9.1.17.2       Spain Narcolepsy Market Revenue And Forecasts to 2027, By Product (US$ Mn)

9.1.17.3       Spain Narcolepsy Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)

10.        Narcolepsy Market – Industry Landscape

10.1      Overview

10.2      Comparative Company Analysis

10.3      Growth Strategies Done By The Companies In The Market, (%)

10.4      Organic Developments

10.4.1     Overview

10.5      Inorganic Developments

10.5.1     Overview

11.        Narcolepsy Market –Key Company Profiles

11.1      Teva Pharmaceutical Industries Ltd.

11.1.1     Key Facts

11.1.2     Business Description

11.1.3     Financial Overview

11.1.4     Product Portfolio

11.1.5     SWOT Analysis

11.1.6     Key Developments

11.2      Jazz Pharmaceuticals Plc

11.2.1     Key Facts

11.2.2     Business Description

11.2.3     Financial Overview

11.2.4     Product Portfolio

11.2.5     SWOT Analysis

11.2.6     Key Developments

11.3      Arena Pharmaceuticals, Inc.

11.3.1     Key Facts

11.3.2     Business Description

11.3.3     Financial Overview

11.3.4     Product Portfolio

11.3.5     SWOT Analysis

11.3.6     Key Developments

11.4      Graymark Healthcare, Inc.

11.4.1     Key Facts

11.4.2     Business Description

11.4.3     Financial Information

11.4.4     Product Portfolio

11.4.5     SWOT Analysis

11.4.6     Key Developments

11.5      Novartis AG

11.5.1     Key Facts

11.5.2     Business Description

11.5.3     Financial Information

11.5.4     Product Portfolio

11.5.5     SWOT Analysis

11.5.6     Key Developments

11.6      Takeda Pharmaceutical Company Limited

11.6.1     Key Facts

11.6.2     Business Description

11.6.3     Financial Information

11.6.4     Product Pipeline

11.6.5     SWOT Analysis

11.6.6     Key Developments

11.7      Mylan N.V.

11.7.1     Key Facts

11.7.2     Business Description

11.7.3     Financial Overview

11.7.4     Product Portfolio

11.7.5     SWOT Analysis

11.7.6     Key Developments

11.8      Bioprojet

11.8.1     Key Facts

11.8.2     Business Description

11.8.3     Financial Overview

11.8.4     Product Portfolio

11.8.5     SWOT Analysis

11.8.6     Key Developments

11.9      Shionogi & Co., Ltd.

11.9.1     Key Facts

11.9.2     Business Description

11.9.3     Financial Overview

11.9.4     Product Portfolio

11.9.5     Product Pipeline

11.9.6     SWOT Analysis

11.9.7     Key Developments

11.10   Ligand Pharmaceuticals, Inc.

11.10.1  Key Facts

11.10.2  Business Description

11.10.3  Financial Overview

11.10.4  Product Portfolio

11.10.5  Product Pipeline

11.10.6  SWOT Analysis

11.10.7  Key Developments

12.        Appendix

12.1      About The Insight Partners

12.2      Glossary Of Terms

12.3      Methodology

12.3.1     Coverage

12.3.2     Secondary Research

12.3.3     Primary Research

 

LIST OF TABLES

 

Table 1.             Europe Narcolepsy With Cataplexy Market Revenue and Forecasts To 2027, By Type (US$ Mn)

Table 2.             Europe Narcolepsy Market Revenue and Forecasts To 2027, By Product (US$ Mn)

Table 3.             Europe Narcolepsy Market Revenue and Forecasts To 2027, By End User (US$ Mn)

Table 4.             Europe Narcolepsy Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 5.             Europe Narcolepsy Market Revenue And Forecasts to 2027, By Product (US$ Mn)

Table 6.             Europe Narcolepsy Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)

Table 7.             Germany Narcolepsy Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 8.             Germany Narcolepsy Market Revenue And Forecasts to 2027, By Product (US$ Mn)

Table 9.             Germany Narcolepsy Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)

Table 10.          UK Narcolepsy Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 11.          UK Narcolepsy Market Revenue And Forecasts to 2027, By Product (US$ Mn)

Table 12.          UK Narcolepsy Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)

Table 13.          France Narcolepsy Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 14.          France Narcolepsy Market Revenue And Forecasts to 2027, By Product (US$ Mn)

Table 15.          France Narcolepsy Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)

Table 16.          Italy Narcolepsy Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 17.          Italy Narcolepsy Market Revenue And Forecasts to 2027, By Product (US$ Mn)

Table 18.          Italy Narcolepsy Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)

Table 19.          Spain Narcolepsy Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 20.          Spain Narcolepsy Market Revenue And Forecasts to 2027, By Product (US$ Mn)

Table 21.          Spain Narcolepsy Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)

Table 22.          Organic Developments Done By Companies

Table 23.          Inorganic Developments Done By Companies

Table 24.          Glossary of Terms, Narcolepsy Market

 

LIST OF FIGURES

 

Figure 1.           US Narcolepsy Market, Revenue (US$ Mn), 2018 & 2027

Figure 2.           Europe Narcolepsy Market By Type, Market Share (%), 2018

Figure 3.           Europe Narcolepsy Market By Product, Market Share (%), 2018

Figure 4.           Europe Narcolepsy Market By Distribution Channel, Market Share (%), 2018

Figure 5.           Narcolepsy Market Segmentation

Figure 6.           Europe PEST Analysis

Figure 7.           Narcolepsy Market Impact Analysis Of Drivers and Restraint

Figure 8.           Europe Narcolepsy Market – Revenue Forecasts and Analysis – 2018- 2027

Figure 9.           Type Market Analysis and Forecasts 2018 and 2027 (%)

Figure 10.        Narcolepsy With Cataplexy Market Revenue and Forecasts To 2027 (US$ Mn)

Figure 11.        Narcolepsy Without Cataplexy Market Revenue and Forecasts To 2027 (US$ Mn)

Figure 12.        Secondary Narcolepsy Market Revenue and Forecasts To 2027 (US$ Mn)

Figure 13.        Product Market Analysis and Forecasts 2018 and 2027 (%)

Figure 14.        Central Nervous System Stimulants Market Revenue and Forecasts To 2027 (US$ Mn)

Figure 15.        Sodium Oxybate Market Revenue and Forecasts To 2027 (US$ Mn)

Figure 16.        Antidepressants Market Revenue and Forecasts To 2027 (US$ Mn)

Figure 17.        Distribution Channel Market Analysis and Forecasts 2018 and 2027 (%)

Figure 18.        Hospital Pharmacies Market Revenue and Forecasts To 2027 (US$ Mn)

Figure 19.        Retail Pharmacies Market Revenue and Forecasts To 2027 (US$ Mn)

Figure 20.        Europe Narcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 21.        Europe Narcolepsy Market Revenue And Forecasts to 2027, By Country (%)

Figure 22.        Germany Narcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 23.        UK Narcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 24.        France Narcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 25.        Italy Narcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 26.        Spain Narcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 27.        Comparative Company Analysis

Figure 28.        Growth Strategies Done By The Companies In The Market, (%)

 

The List of Companies - Europe Narcolepsy Market

1. Teva Pharmaceutical Industries Ltd.
2. Jazz Pharmaceuticals plc
3. Arena Pharmaceuticals, Inc.
4. Graymark Healthcare, Inc.
5. Novartis AG
6. Takeda Pharmaceutical Company Limited
7. Mylan N.V.
8. BIOPROJET
9. Shionogi & Co., Ltd.
10. Ligand Pharmaceuticals, Inc

 

• Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Europe narcolepsy market.

• Highlights key business priorities in order to assist companies to realign their business strategies.

• The key findings and recommendations highlight crucial progressive industry trends in the Europe narcolepsy market, thereby allowing players across the value chain to develop effective long-term strategies.

• Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

• Scrutinize in-depth regional market trends and outlook coupled with the factors driving the market, as well as those hindering it.

• Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

Report Code
Full Name
Country Name	Select Country Afghanistan Aland Islands Albania Algeria American Samoa Andorra Angola Anguilla Antarctica Antigua and Barbuda Argentina Armenia Aruba Australia Austria Azerbaijan Bahamas Bahrain Bangladesh Barbados Belarus Belgium Belize Benin Bermuda Bhutan Bolivia Bosnia and Herzegovina Botswana Bouvet Island Brazil British Indian Ocean Territory Brunei Darussalam Bulgaria Burkina Faso Burundi Cambodia Cameroon Canada Cape Verde Caribbean Netherlands Cayman Islands Central African Republic Chad Chile China Christmas Island Cocos (Keeling) Islands Colombia Comoros Congo Congo, Democratic Republic of Cook Islands Costa Rica Côte d’Ivoire Croatia Cuba Curaçao Cyprus Czech Republic Denmark Djibouti Dominica Dominican Republic Ecuador Egypt El Salvador Equatorial Guinea Eritrea Estonia Ethiopia Falkland Islands Faroe Islands Fiji Finland France French Guiana French Polynesia French Southern Territories Gabon Gambia Georgia Germany Ghana Gibraltar Greece Greenland Grenada Guadeloupe Guam Guatemala Guernsey Guinea Guinea-Bissau Guyana Haiti Heard and McDonald Islands Honduras Hong Kong Hungary Iceland India Indonesia Iran Iraq Ireland Isle of Man Israel Italy Jamaica Japan Jersey Jordan Kazakhstan Kenya Kiribati Kuwait Kyrgyzstan Lao People's Democratic Republic Latvia Lebanon Lesotho Liberia Libya Liechtenstein Lithuania Luxembourg Macau Macedonia Madagascar Malawi Malaysia Maldives Mali Malta Marshall Islands Martinique Mauritania Mauritius Mayotte Mexico Micronesia, Federated States of Moldova Monaco Mongolia Montenegro Montserrat Morocco Mozambique Myanmar Namibia Nauru Nepal New Caledonia New Zealand Nicaragua Niger Nigeria Niue Norfolk Island North Korea Northern Mariana Islands Norway Oman Pakistan Palau Palestine, State of Panama Papua New Guinea Paraguay Peru Philippines Pitcairn Poland Portugal Puerto Rico Qatar Réunion Romania Russian Federation Rwanda Saint Barthélemy Saint Helena Saint Kitts and Nevis Saint Lucia Saint Vincent and the Grenadines Saint-Martin (France) Samoa San Marino Sao Tome and Principe Saudi Arabia Senegal Serbia Seychelles Sierra Leone Singapore Sint Maarten (Dutch part) Slovakia Slovenia Solomon Islands Somalia South Africa South Georgia and the South Sandwich Islands South Korea South Sudan Spain Sri Lanka St. Pierre and Miquelon Sudan Suriname Svalbard and Jan Mayen Islands Swaziland Sweden Switzerland Syria Taiwan Tajikistan Tanzania Thailand The Netherlands Timor-Leste Togo Tokelau Tonga Trinidad and Tobago Tunisia Turkey Turkmenistan Turks and Caicos Islands Tuvalu Uganda Ukraine United Arab Emirates United Kingdom United States United States Minor Outlying Islands Uruguay Uzbekistan Vanuatu Vatican Venezuela Vietnam Virgin Islands (British) Virgin Islands (U.S.) Wallis and Futuna Islands Western Sahara Yemen Zambia Zimbabwe
Email Id
Phone Number
Job Title
Company
Requirement
Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.